Skip to content
10-Q

Quarterly Report

OWC Pharmaceutical Research Corp.

0001493152-19-017031

← back to feed
Filed
Nov 13, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 12, 2019 262.33M sh
Shares Diluted Q3 2019 · Sep 30, 2019 232.58M sh
Shares Diluted Q3 2019 · Sep 30, 2019 196.7M sh
Shares Diluted restated Q3 2019 · Sep 30, 2018 148.98M sh
Shares Diluted Q3 2019 · Sep 30, 2018 149.25M sh
Capex Q3 2019 · Sep 30, 2019 $2K
Capex restated Q3 2019 · Sep 30, 2018 $23K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$1.99M
Operating Cash Flow restated Q3 2019 · Sep 30, 2018 −$1.75M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $1.47M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $3.46M
Stockholders Equity Q3 2019 · Sep 30, 2019 −$4.01M
Stockholders Equity Q3 2019 · Jun 30, 2019 −$3.04M
Stockholders Equity Q3 2019 · Dec 31, 2018 −$9.44M
Stockholders Equity restated Q3 2019 · Sep 30, 2018 −$3.79M
Stockholders Equity Q3 2019 · Jun 30, 2018 −$2.18M
Stockholders Equity restated Q3 2019 · Dec 31, 2017 $791K
Current Liabilities Q3 2019 · Sep 30, 2019 $543K
Current Liabilities Q3 2019 · Dec 31, 2018 $438K
Total Liabilities Q3 2019 · Sep 30, 2019 $1.47M
Total Liabilities Q3 2019 · Dec 31, 2018 $10.77M
Current Assets Q3 2019 · Sep 30, 2019 $1.7M
Current Assets Q3 2019 · Dec 31, 2018 $3.52M
Total Assets Q3 2019 · Sep 30, 2019 $1.77M
Total Assets Q3 2019 · Dec 31, 2018 $3.55M
Eps Diluted Q3 2019 · Sep 30, 2019 $0.00
Eps Diluted Q3 2019 · Sep 30, 2019 $0.02
Eps Diluted Q3 2019 · Sep 30, 2018 −$0.01
Eps Diluted Q3 2019 · Sep 30, 2018 −$0.05
Eps Basic Q3 2019 · Sep 30, 2019 $0.00
Eps Basic Q3 2019 · Sep 30, 2019 $0.02
Eps Basic Q3 2019 · Sep 30, 2018 −$0.01
Eps Basic Q3 2019 · Sep 30, 2018 −$0.04
Rd Expense Q3 2019 · Sep 30, 2019 $168K
Rd Expense Q3 2019 · Sep 30, 2019 $773K
Rd Expense restated Q3 2019 · Sep 30, 2018 $126K
Rd Expense restated Q3 2019 · Sep 30, 2018 $493K
Net Income Q3 2019 · Sep 30, 2019 −$287K
Net Income Q3 2019 · Sep 30, 2019 $6.42M
Net Income restated Q3 2019 · Sep 30, 2018 −$992K
Net Income restated Q3 2019 · Sep 30, 2018 −$5.18M
Revenue Q3 2019 · Dec 31, 2016 $50K